Vandana Singh - Spark Newswire

1 minute read

Shionogi’s COVID-19 Pill, Based On Similar Action Like Pfizer’s, Sees Around $2B In Annual Sales

Today, 7:00 AM

Japanese pharmaceutical company Shionogi & Co Ltd's CEO believes its COVID-19, Xocova, pill can generate $2 billion in annual sales if it secures FDA approval. The company expects U.S. approval by late 2024.

PFE

1 minute read

Biophytis Seeks Early Access Authorization For Its COVID-19 Treatment In France

By Vandana Singh

Today, 7:00 AM

Biophytis SA (NASDAQ:BPTS) has begun the early access application process in France for Sarconeos (BIO101) for the treatment of severe COVID-19.…

BPTS

1 minute read

Iradimed Notifies Potential Issue With Certain Syringe Adapter Sets During Use

By Vandana Singh

Today, 7:00 AM

Iradimed Corporation (NASDAQ:IRMD) notified a potential issue with some 1057 Syringe Adapter Sets related to the syringe venting function during use.…

IRMD

1 minute read

iRhythm’s Q4 Earnings Beat Expectations, Analysts Remain Bullish On Upcoming Catalysts

By Vandana Singh

Today, 7:00 AM

iRhythm Technologies Inc (NASDAQ:IRTC) reported Q4 FY22 revenue of $112.6 million, up 37.7% Y/Y beating the consensus of $110.26 million.…

IRTC

1 minute read

Goldman Sachs Under Expanded Investigation For Its Credit Card Business

By Vandana Singh

Today, 7:00 AM

AAPL

1 minute read

FDA Slams Break On Fulcrum Therapeutics’ Sickle Cell Disease Study, Shares Plummet

By Vandana Singh

Today, 7:00 AM

The FDA verbally informed Fulcrum Therapeutics Inc (NASDAQ:FULC) that it has issued a full clinical hold regarding the Investigational New Drug (IND)…

FULC

1 minute read

Novartis Takes Down $80M NASH Pact With Pliant Therapeutics

By Vandana Singh

Today, 7:00 AM

Novartis AG (NYSE:NVS) has decided to terminate the Collaboration and License Agreement with Pliant Therapeutics, Inc.(NASDAQ:PLRX), announced in 2019. Novartis told…

NVS